MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak

Wrocław 7 trials 5 recruiting

7 Registered trials

5 Currently recruiting

Organisation

MIGRE Polskie Centrum Leczenia Migreny Anna Gryglas-Dworak

Location

Wrocław, Poland

Identifier

ORL-000006468

Address

ul. Łubinowa 12/7, 52-210, Poland

Departments

N/A
NA

Clinical trials at this site (7)

Search interface

An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients w… Recruiting

2023-507853-13-00 Ulcerative Colitis 4 2025-02-25
A Study to Assess the Adverse Events and Change in Disease Activity of Atogepant Oral Tablets in Pediatric Participants with Chronic Migrain… Recruiting

2024-513836-28-00 Chronic Migraine 5 2025-06-23
A study with eptinezumab in children and adolescents (6 to 17 years) with chronic or episodic migraine (REJOIN) Recruiting

2022-502917-27-00 Migraine 5 2023-03-07
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine (PROSPECT-2) Recruiting

2024-510656-13-00 Migraine 5 2022-11-08
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention in Ch… Recruiting

2024-512382-13-00 Migraine (with or without aura) 5 2022-10-04
A dose-finding trial with LU AG90222 in adults with migraine who have not been helped by prior preventative treatments. Ended

2023-508821-28-00 Migraine 4 2024-08-14
Phase 3 Open label clinical trial with oral Atogepant for the prevention of migraine Ended

2023-507096-21-00 Chronic or Episodic Migraine (Migraine without aura, mi 5 2021-08-16